Konakion Mm Ampoules

Phytomenadione, the active ingredient in Konakion Mm Ampoules, is a vitamin K presented as an ampoule for intravenous use. It treats vitamin K deficiency, helps prevent bleeding in newborns, and reverses anticoagulant therapy in patients requiring rapid coagulation restoration. GNH USA supplies Konakion Mm Ampoules as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare facilities worldwide.

Konakion Mm Ampoules provides vitamin K activity for disorders of coagulation. - Vitamin K deficiency: restores normal clotting factor function in patients with insufficient vitamin K levels. - Newborns at risk of hemorrhage: prevents bleeding by supplying essential vitamin K shortly after birth. - Reversal of anticoagulant therapy: rapidly corrects coagulopathy caused by vitamin K antagonist drugs such as warfarin.

Common Side Effects: - Injection site pain - Mild flushing - Nausea

Serious or Rare Side Effects: - Anaphylaxis - Severe allergic reaction - Thrombosis

Precautions should be observed when using Konakion Mm Ampoules. - Hypersensitivity: avoid in patients with known allergy to phytomenadione or excipients. - Coagulation monitoring: check clotting parameters before and after administration. - Administration rate: give slowly to reduce risk of hypotension. - Liver disease: assess hepatic function as it may affect vitamin K metabolism. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potential drug interactions must be considered. Major Interactions (Avoid): - Concurrent use of other vitamin K preparations may lead to excess coagulation. - High‑dose vitamin K antagonists (e.g., warfarin) may have reduced efficacy when phytomenadione is administered.

Moderate Interactions (Monitor Closely): - Broad‑spectrum antibiotics that alter gut flora can affect endogenous vitamin K status. - Cefoperazone may increase bleeding risk when combined with vitamin K deficiency. - Oral contraceptives may augment clotting tendency when used together with vitamin K supplementation.